Metabolic Changes Induced by Genetically Modified Potatoes

Charite University, Berlin, Germany50 enrolled

Overview

Starches from genetically modified potatoes, which differed in terms of amylose, amylopectin and phosphate content, were tested in a human randomized controlled trial.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

BASIC_SCIENCE

Masking

SINGLE

Enrollment

Conditions

Glucose Metabolism Endocrine Metabolism Satiety

Interventions

Genetically modified potatoesOTHER

Starch from genetically modified potatoes

Eligibility

Sex: MALEMin age: 18 YearsMax age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * healthy males Exclusion Criteria: * no acute oder severe chronic diseases

Locations (1)

Charité, Dept. of Endocrinology, Diabetes and Nutrition

Berlin, State of Berlin, Germany

RECRUITING

Outcomes

Primary Outcomes

Glucose metabolism

Time frame: 2 days

Central Contacts

Joachim Spranger, MD

CONTACT

0049308445 joachim.spranger@charite.de

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.